Follow
Andrew Gaynor
Andrew Gaynor
PhD Candidate, University of Delaware
Verified email at udel.edu
Title
Cited by
Cited by
Year
Cell-surface expression of neuron-glial antigen 2 (NG2) and melanoma cell adhesion molecule (CD146) in heterogeneous cultures of marrow-derived mesenchymal stem cells
KC Russell, HA Tucker, BA Bunnell, M Andreeff, W Schober, AS Gaynor, ...
Tissue engineering Part A 19 (19-20), 2253-2266, 2013
502013
Synthetic biology approaches for targeted protein degradation
RP Chen, AS Gaynor, W Chen
Biotechnology advances 37 (8), 107446, 2019
172019
Induced prodrug activation by conditional protein degradation
AS Gaynor, W Chen
Journal of biotechnology 260, 62-66, 2017
82017
Tunable modulation of antibody‐antigen interaction by protease cleavage of protein M
H Kim, A Gaynor, W Chen
Biotechnology and Bioengineering 116 (11), 2834-2842, 2019
72019
Conditional Protein Rescue by Binding-Induced Protective Shielding
AS Gaynor, W Chen
ACS Synthetic Biology 9 (10), 2639-2647, 2020
22020
Conditional Protein Rescue (CPR) by Binding-Induced Protective Shielding
AS Gaynor, W Chen
bioRxiv, 2020.06. 16.154435, 2020
2020
Developing conditional protein rescue for synthetic proten-based logic circuits towards the detection and treatment of cancer
AS Gaynor
University of Delaware, 2020
2020
Tunable, post-translational method for controlling prodrug converting enzymes in cancer cells
A Gaynor, W Chen
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 255, 2018
2018
Modulating Antibody/Antigen Affinity By Triggered Assembly and Disassembly of an Artificially Split Protein M
H Kim, A Gaynor, W Chen
2017 AIChE Annual Meeting, 2017
2017
Controlled protein degradation for the conditional survival of cancer suicide enzymes
A Gaynor, W Chen
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 253, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–10